Tag - pharmaceuticals-medicine

 
Menu
Search
 
May 08, 2024
 

Today's print edition

Home Delivery
Subscribe for more access

PHARMACEUTICALS MEDICINE

Japan Times
BUSINESS
Nov 30, 2022
Eisai Alzheimer’s drug sparks debate over benefits as risks like brain bleeding emerge
The key issue is whether the modest slowing of the disease is meaningful to individual patients and their families, especially in light of the potential side effects.
Japan Times
BUSINESS / Markets
Nov 29, 2022
Eisai and Biogen plunge after report of second death in Alzheimer’s trial
The case involved a 65-year-old woman who died of a massive brain hemorrhage after suffering a stroke and a type of brain swelling and bleeding in an Eisai trial, a report said.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
WORLD / Science & Health
Jul 26, 2022
Siga and peers rise on optimism over therapies to treat monkeypox
It has been a bumpy few months for shares of firms tied to the outbreak, as investors have piled in only to rush out on uncertainty about what medicine could be needed.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
It's a vast project that shows how governments are growing increasingly concerned about China's stranglehold over drug supplies — as well as the challenges they face in loosening it.
Japan Times
WORLD / Science & Health
Jan 12, 2022
Biogen stung as U.S. limits coverage of Alzheimer’s therapy
Private insurers in the U.S. have mostly declined to cover Aduhelm, saying they need more proof of its efficacy and that benefits outweigh risks like brain swelling.
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.
Japan Times
BUSINESS
Jun 9, 2021
Eisai sees potential of new Alzheimer's drug but costs remain concern
The approval by the U.S. Food and Drug Administration of the drug Aduhelm raised hopes, but patients can expect to be charged $56,000 a year.
Japan Times
BUSINESS / FOCUS
Jun 4, 2021
Chinese drugmakers take aim at lucrative U.S. anti-cancer market
In recent years, medicines that free the immune system to attack tumors have become blockbusters in a $150 billion global market.
Japan Times
JAPAN / Science & Health
Jun 12, 2020
Daiichi Sankyo sees clinical test for genetic COVID-19 vaccine in March
The vaccine contains messenger RNA that causes cells to produce proteins that could trigger the body to produce effective antibodies.
Tokuryū, a new crime menace in Japan, emerges from the shadows
The National Police Agency coined the term "tokuryū" to classify individuals involved in dark part time jobs and quasi-gangsters, using the words "tokumei" (anonymous) and "ryūdo" (fluid) to reflect their characteristics.
Is Modi’s party heading for a stunning election loss?
Indian Prime Minister Narendra Modi's campaign tactics have escalated, including anti-Muslim rhetoric and fearmongering, reflecting his ruling party's desperation.
Japan's labor crunch persists despite slight improvement
Over 300 companies went out of business in fiscal 2023 due to labor shortages, according to Teikoku Databank.
Excitement returns to tourist spots in Japan one year on
On May 2, the streets of Arashiyama, a well-known tourist destination in Kyoto, were filled with tourists, including many from abroad, ahead of the four-day weekend.
After blockbuster boxing victory, what next for ‘Monster’ Inoue?
Naoya Inoue celebrates his victory over Luis Nery in their IBF-WBA-WBC-WBO super bantamweight title boxing match at Tokyo Dome on Monday.
How a Japanese scientist is turning the climate crisis into music
A screencap of a performance of Hiroto Nagai's “String Quartet No. 1 ‘Polar Energy Budget’” by the PRT Quartet
Japan’s tween skateboarders get head start on preparations for 2028 Olympics
Ibuki Matsumoto competes at an event in Osaka on April 21.
Pentagon reveals drone types for Replicator program to counter China
A U.S. Naval Special Warfare Operator fires a Switchblade 300 loitering munition during training exercises in Fallon, Nevada, last July. The U.S. Defense Department plans to use small drones — known in the Pentagon as “all-domain attritable autonomous systems” — to help counter Chinese military systems and tactics.
As visitors surge, Japan seeks ways to make tourism eco-friendly
Much like other hot spots across Okinawa, Onna has diligently strived to captivate both domestic and international tourists, while at the same time grappling with the environmental strain induced by the influx of visitors.
Kishida talks up bolstered Latin American ties as China cements position
Prime Minister Fumio Kishida holds a news conference in Sao Paulo on Saturday.

Podcast

From easily navigable train stations to the helpfulness of its municipal staff, Tokyo has earned high praise for its commitment to accessibility for disabled travelers.
[Rebroadcast] Japan is doing better on accessibility than you may think

Longform

Rows of irises resemble a rice field at the Peter Walker-designed Toyota Municipal Museum of Art.
The 'outsiders' creating some of Japan's greenest spaces
By Stephen Mansfield

SUSTAINABLE JAPAN

Vol. 35: Travel in time — and stay there
Vol. 35: Travel in time — and stay there

SPECIAL SUPPLEMENTS note

Read more

SUPPLEMENTS BINDER